Drawing for ENTAC

USPTO serial 97310188

ENTAC

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
YONTEF, DAVID ERIC
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ENTAC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anuj Desai

Anuj Desai ARNALL GOLDEN GREGORY LLP171 17TH ST NWSUITE 2100ATLANTA, GA 30363

Goods and services

ClassDescriptionStatusFirst use
009Downloadable mobile applications for verifying and displaying identity and health information; downloadable computer application software for mobile phones, namely, software for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer application software for mobile phones, namely, software for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer application software for mobile phones, namely, software for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; downloadable computer application software for mobile phones and tablets, namely, software for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer application software for mobile phones and tablets, namely, software for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer application software for mobile phones and tablets, namely, software for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; downloadable computer programs using artificial intelligence for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer programs using artificial intelligence for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer programs using artificial intelligence for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; downloadable computer software using artificial intelligence for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer software using artificial intelligence for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; downloadable computer software using artificial intelligence for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; downloadable software as a Medical Device (SaMD) for diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systems; electronic products for the generation, measurement, and analysis of audio signals, namely, audio analyzers; recorded computer application software for medical devices containing computers therein, namely, software for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems and for diagnosing diseases and disorders associated therewith; recorded computer application software for medical devices containing computers therein, namely, software for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; recorded computer programs using artificial intelligence for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; recorded computer programs using artificial intelligence for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; recorded computer programs using artificial intelligence for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; recorded computer software using artificial intelligence for viewing digital image and photographic data concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; recorded computer software using artificial intelligence for displaying health data and metrics concerning the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; recorded computer software using artificial intelligence for enabling health practitioners to analyze and review medical data and information before making clinical decisions in postoperative patient care situations; recorded software as a Medical Device (SaMD) for diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systems; software as a Medical Device (SaMD), downloadable, for analyzing heart rate data; software as a Medical Device (SaMD), downloadable, for diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systems; software as a Medical Device (SaMD), recorded, for diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systemsACTIVE—
010Medical devices for use in diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systems; medical devices for use in treating or diagnosing postoperative diseases and disorders associated with a patient's digestive, pulmonary, vascular and cardiovascular systems with integrated recorded operating system software, sold as a unit; medical hearing instruments and parts of such devices; all of the foregoing, excluding surgical instruments and apparatusACTIVE—
035Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management servicesACTIVE—
042Clinical research in the field of science and medicine relating to the postoperative health of a patient's digestive, pulmonary, vascular and cardiovascular systems; data warehousing; research and development and consultation related thereto in the field of science and medicine relating to postoperative health predictions concerning a patient's digestive, pulmonary, vascular and cardiovascular systems; research and development in the field of science and medicine relating to postoperative health predictions concerning a patient's digestive, pulmonary, vascular and cardiovascular systems; consulting services for others in the field of design, planning, and implementation project management of clinical trials for others in the field of postoperative health concerning a patient's digestive, pulmonary, vascular and cardiovascular systems; providing a web site featuring temporary use of non-downloadable software for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing a website featuring non-downloadable software for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing a website featuring non-downloadable software using artificial intelligence for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing a website featuring on-line non-downloadable software that enables users to display and download clinical data and gain authorized access to databases featuring clinical data; providing a website featuring resources, namely, non-downloadable software for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing a web site featuring technology for enabling physicians to access resources in clinical medicine; providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; providing information in the field of clinical research via a website; providing information on clinical studies via an interactive website; providing medical and scientific research information in the field of clinical trials; providing temporary use of a web-based software application for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing temporary use of a non-downloadable web application for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; providing temporary use of on-line non-downloadable software and applications using artificial intelligence for displaying and downloading clinical data and for authorizing access to databases featuring clinical data; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of postoperative health concerning a patient's digestive, pulmonary, vascular and cardiovascular systemsACTIVE—
044Clinical medical consultation services; providing health information via a website; providing a website featuring information in the field of a patient's postoperative digestive, pulmonary, vascular and cardiovascular health; providing information in the field of a patient's postoperative digestive, pulmonary, vascular and cardiovascular health via a websiteACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 2, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 2, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 2, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 2, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 7, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 6, 2026EX5GSOU EXTENSION 5 GRANTED—
Mar 11, 2026EXT5SOU EXTENSION 5 FILED—
Mar 11, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 26, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 25, 2025EX4GSOU EXTENSION 4 GRANTED—
Sep 25, 2025EXT4SOU EXTENSION 4 FILED—
Sep 25, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 26, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 26, 2025EX3GSOU EXTENSION 3 GRANTED—
Mar 25, 2025EXT3SOU EXTENSION 3 FILED—
Mar 25, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 24, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 24, 2024EX2GSOU EXTENSION 2 GRANTED—
Sep 24, 2024EXT2SOU EXTENSION 2 FILED—
Sep 24, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 27, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 26, 2024EX1GSOU EXTENSION 1 GRANTED—
Mar 26, 2024EXT1SOU EXTENSION 1 FILED—
Mar 26, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 26, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 1, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 1, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 12, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 28, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 24, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 23, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 23, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 13, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 13, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Dec 23, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 19, 2022DOCKASSIGNED TO EXAMINER—
Mar 17, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 17, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance